Page 1 Investors Presentation, Final Figures Financial Year 2014 / 2015 Investors Presentation Final Figures Financial Year 2014 / 2015 Solutions made in plastic
Page 2 Investors Presentation, Final Figures Financial Year 2014 / 2015 Content 1. Highlights of financial year 2014 / 2015 2. Overview key figures (past 12 quarters) 3. FY sales revenues, EBITDA & EBIT 4. FY Cash flow 5. Consolidated statement 6. Events after the Reporting Period & Outlook Headquarter Balda AG, Bad Oeynhausen
Page 3 Investors Presentation, Final Figures Financial Year 2014 / 2015 1. Highlights of financial year 2014 / 2015 Sales revenue increase of 21.1 % to EUR 85.4 million EBITDA continues positive operative trend EBIT negative because of one-time extraordinary items due to value adjustments in America segment and one-off effects Higher demand of customer orders in both segments In November 2014 Balda has founded a new subsidiary in Timisaora, Romania Balda has acquired the patent for a dosing pipette for liquid medication Loss of major eyewear customer, but acquisition of new - yet small - customer for individual children s eyewear Share of sales revenues of Balda AG regarding its markets Agriculture 2 % Electronics 43.9 % Europe 56.1 % America 4 % Automotive 4 % Eyewear 15 % Healthcare 75 % Source: FC 2013/2014 Balda proves organic growth strategy to be successful
Page 4 Investors Presentation, Final Figures Financial Year 2014 / 2015 2. Overview key figures Sales revenues 1 [in EUR million] 25 20 15 10 5 0 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 2012 / 2013 2013 / 2014 2014 / 2015 EBITDA 1 [in EUR million] before extraordinary items 5 0-5 -10-15 EBIT 12 [in EUR million] after extraordinary items 5 0-5 -10-15 1 2012 short fiscal year; Q1 and Q2 2012 / 2013 including BSM; Q3 2012 / 2013 until today including US-operations 2 EBIT in Q4 2012 / 2013 was affected by impairment losses of approx. EUR 10 million on investments of acquired US-companies; EBIT in Q4 2013 / 2014 was affected by restructuring measurements with effects of approx. EUR 2.3 million ; EBIT in Q3 and Q4 2014 / 2015 strongly affected by one-time extraordinary items
Page 5 Investors Presentation, Final Figures Financial Year 2014 / 2015 3. Growth in financial year 2014 / 2015 [in EUR million] 85.4 70.5 37.5 31.8 38.7 4.0 47.9 6.4-4.7-12.1 1 July 2013 30 June 2014 1 July 2014 30 June 2015 Sales revenues Europe Sales revenues America EBITDA EBIT
Page 6 Investors Presentation, Final Figures Financial Year 2014 / 2015 4. Cash flow of financial year 2014 / 2015 [in EUR million] 179.7 7.7 2.6-24.2-0.18-89.3 1 July 2013 30 June 2014 1 July 2014 30 June 2015 Cash flow from operating activities Cash flow from investing activities Cash flow from financing activities
Page 7 Investors Presentation, Final Figures Financial Year 2014 / 2015 5. Consolidated statement as of 30 June 2015 Assets and Equity & Liabilities [in EUR million] 265.8 Assets Non-current assets include 208.7 234.1 - Property, plant and equipment EUR 19.6 million - Financial investments contains money deposits (bonded loans) EUR 15.0 million Current assets divide in - Inventories EUR 9.1 million - Trade receivables EUR 12.8 million - Cash and cash equivalents EUR 139.5 million - Other current assets EUR 47.1 million Current tax assets EUR 0.2 million 57.1 31.7 30 June 2015 Current assets Equity Non-current assets Liabilities Equity and liabilities Equity ratio is 88.1 % Liabilities include - Trade payables EUR 5.9 million - Advance payments received EUR 3.6 million - Other EUR 22.3 million
Page 8 Investors Presentation, Final Figures Financial Year 2014 / 2015 6. Events after the Reporting Period & Outlook Sale of all operating subsidiaries Subject to the approval of AGM and anti-trust authorities If approved, sale will be retroactive as of 1 July 2015 Supervisory and Management Boards suggested payment of extraordinary dividend Reduction of shared capital at a 10:1 ratio (subject to approval of sale by AGM) Supervisory Board will introduce new strategies at AGM AGM to decide on new business purpose and company name of the Group
Page 9 Investors Presentation, Final Figures Financial Year 2014 / 2015 Q&A-Session Solutions made in plastic
Page 10 Investors Presentation, Final Figures Financial Year 2014 / 2015 Investors Presentation Final Figures Financial Year 2014 / 2015 Thank you for your attention!
Page 11 Investors Presentation, Final Figures Financial Year 2014 / 2015 Investors Presentation Final Figures Financial Year 2014 / 2015 Thank you for your attention!